Follow The Filings

ELAN Elanco Animal Health Inc.

Health Care, filed as ELANCO ANIMAL HEALTH INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 2 managers in 2026 Q2

  • 1 Owner
  • $1K

Who owns ELAN

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust <0.01% Hold 56 $1K History

1 current, options excluded

Insider trades

Open-market buys and sales by ELAN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ELAN insider trades
  • $2.6M bought by 7 insiders
  • None no sales outside a trading plan
  • $100K sold by 1 insider under 10b5-1 plans
  1. Timothy J Bettington See Remarks
    Planned sale
    $100K 4,350 shares at $23.00 3% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Lawrence Erik Kurzius Director
    Buy
    $936K 40,000 shares at $23.40 +27% to stake
    Traded Aug 20 Filed Aug 21
    ↗
  3. Shiv O'Neill Gc and Corp Sec
    Buy
    $94K 3,998 shares at $23.58 +4.8% to stake
    Traded Aug 18 Filed Aug 18
    ↗
  4. Michael J Harrington Director
    Buy
    $109K 5,000 shares at $21.82 +4% to stake
    Traded Aug 12 Filed Aug 13
    ↗
  5. Robert M VanHimbergen CFO
    Buy
    $97K 4,200 shares at $23.08 +3.2% to stake
    Traded Aug 7 Filed Aug 10
    ↗
  6. Paul Herendeen Director
    Buy
    $237K 10,000 shares at $23.69 +9.8% to stake
    Traded Aug 7 Filed Aug 10
    ↗
  7. Rajeev A. Modi See Remarks
    Buy
    $100K 4,911 shares at $20.35 +3.2% to stake
    Traded May 15 Filed May 19
    ↗
  8. Jeffrey N Simmons CEO
    Buy
    $100K 4,971 shares at $20.09 +3% to stake
    Traded May 15 Filed May 19
    ↗
  9. Lawrence Erik Kurzius Director
    Buy
    $213K 10,000 shares at $21.30 +8.2% to stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗
  10. Rajeev A. Modi See Remarks
    Buy
    $96K 4,500 shares at $21.33 +3.8% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
  11. Robert M VanHimbergen CFO
    Buy
    $150K 6,950 shares at $21.64 +5.9% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗
  12. Jeffrey N Simmons CEO
    Buy
    $478K 22,000 shares at $21.75 +15% to stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 50 stock grants, 22 share withholdings for taxes, and 1 gift.

Congress

1 member of Congress traded ELAN in the last three years: 0 buys and 1 sale. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025

SEC filings

Recent issuer filings from EDGAR, 3 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q 10-Q FOR THE PERIOD ENDED JUNE 30, 2026 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 10 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.42B $4.44B $4.72B
Gross profit * $2.49B $2.44B $2.59B
Gross margin * 56.3% 54.9% 55.0%
Net income -$1.23B $0.338B -$0.232B
Net margin * -27.9% 7.6% -4.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.41B $3.22B $3.46B
Total non-current assets * $10.96B $9.4B $9.9B
Total assets $14.36B $12.61B $13.36B
Total current liabilities $1.24B $1.32B $1.6B
Total non-current liabilities * $6.9B $5.2B $5.21B
Total equity $6.22B $6.1B $6.55B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $271M $541M $560M
Cash from investing -$0.169B $1.16B -$0.279B
Cash from financing -$0.083B -$1.49B -$0.275B
Net change in cash $7M $116M $77M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.